Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

In this session, Dr Joyce O'Shaughnessy from Texas Oncology discusses strategies for optimizing endocrine therapy for patients with metastatic hormone receptor positive breast cancer.

[@HL-qv3yd]

🙏🙏🙏🙏

[@maryhassell5842]

Joyce Shaughnessy said it is a drag topic… drag to talk about it? Try having it. Then see how much a drag it is. Words matter. Doctors who are so impressed with their knowledge have no flipping clue.

[@CatFromFL]

You said it Mary! Joyce doesn’t have a clue with that remark to this audience.

[@oligreen1192]

Totally agree

[@thyda9163]

🙏🙏🙏🥲